Shares of Biocon slipped 5 per cent to Rs 254.15 on the BSE in Friday’s intra-day trade as the company’s unit Biocon Biologics will sell its Indian branded formulations businesses to Eris Lifesciences
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
